<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00538408</url>
  </required_header>
  <id_info>
    <org_study_id>H-D-2007-0041</org_study_id>
    <nct_id>NCT00538408</nct_id>
  </id_info>
  <brief_title>Whole Body Magnetic Resonance Angiography in Ischemic Patients</brief_title>
  <official_title>Whole Body Magnetic Resonance Angiography in Patients With Symptomatic Peripheral Ischemia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Copenhagen University Hospital at Herlev</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Copenhagen University Hospital at Herlev</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To investigate the diagnostic performance of whole body magnetic resonance angiography
      (WB-MRA) using two different magnetic resonance contrast agents.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Atherosclerosis of the lower leg arteries is a common disease. Patients with this condition
      has symptoms of ischemia, for instance intermittent claudication (pain during exercise).
      Diagnosis of atherosclerosis in the legs is normally done with an interventional x-ray-based
      angiography (DSA- digital subtraction angiography). This is uncomfortable for the patient,
      and associated with risks of complications (bleeding, vascular damage, embolism).A novel
      approach to diagnosing atherosclerosis is the use of magnetic resonance angiography. A
      variant of this is the whole body magnetic resonance angiography(WB-MRA), that produce a
      picture of the arteries in almost the whole body (excluding the coronary arteries). WB-MRA
      has a number of advantages compared to DSA. It does not use ionizing radiation, is not
      invasive, uses a contrast medium with fewer side affects and finally gives a covers a great
      deal of the arteries in the body.

      This study will compare WB-MRA with DSA in patients with symptoms of peripheral
      atherosclerosis in the lower legs. We will investigate 2 different contrast agents used for
      WB-MRA. The patients will be randomized to receive either the contrast medium Dotarem or the
      contrast medium Vasovist. In both groups we will compare the results of WB-MRA with DSA.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2007</start_date>
  <completion_date type="Anticipated">January 2010</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Vascular diagnostic quality on the WB-MRA. Degree of arterial stenosis on the WB-MRA.</measure>
  </primary_outcome>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Atherosclerosis</condition>
  <condition>Intermittent Claudication</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Whole body magnetic resonance angiography (dotarem)</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Whole body magnetic resonance angiography (vasovist)</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Symptomatic lower extremity ischemia (claudication, ischemic wounds)

          -  Referred to digital subtraction angiography (DSA)

        Exclusion Criteria:

          -  Renal insufficiency (GFR &lt; 30 ml/min)

          -  Contra-indications for MRI-examination (claustrophobia, metal-implants, pacemaker)

          -  Dementia

          -  Pregnancy/lactation

          -  Allergy to gadolinium based MRI contrast agents

          -  Acute disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Henrik S Thomsen, Prof.</last_name>
    <role>Study Chair</role>
    <affiliation>University Hospital at Herlev Copenhagen Denmark</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yousef W. Nielsen, MD</last_name>
    <phone>+45 44884391</phone>
    <email>yujwni01@heh.regionh.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>jakob M MÃ¸ller, M.Sc.</last_name>
    <phone>+ +45 44883996</phone>
    <email>jaml@heh.regionh.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Radiology, Herlev University Hospital</name>
      <address>
        <city>Herlev, Copenhagen</city>
        <zip>DK-2730</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yousef W. Nielsen, MD.</last_name>
      <phone>+45 4488 4391</phone>
      <email>yujwni01@heh.regionh.dk</email>
    </contact>
    <investigator>
      <last_name>Yousef W. Nielsen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>February 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 1, 2007</study_first_submitted>
  <study_first_submitted_qc>October 1, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 2, 2007</study_first_posted>
  <last_update_submitted>February 1, 2009</last_update_submitted>
  <last_update_submitted_qc>February 1, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 3, 2009</last_update_posted>
  <responsible_party>
    <name_title>Yousef Nielsen</name_title>
    <organization>Herlev University Hospital</organization>
  </responsible_party>
  <keyword>Magnetic resonance</keyword>
  <keyword>whole body</keyword>
  <keyword>angiography</keyword>
  <keyword>vasovist</keyword>
  <keyword>gadofosveset</keyword>
  <keyword>dotarem</keyword>
  <keyword>blood pool agent</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atherosclerosis</mesh_term>
    <mesh_term>Intermittent Claudication</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

